Proof of Concept for High-Dose Cannabidiol Pretreatment to Antagonize Opioid Induced Persistent Apnea

pubmed logo

“Using a mouse equivalent of FDA-approved cannabidiol (CBD) dosing, we found high dose CBD affects opioid induced persistent apnea (OIPA), the principal cause of opioid related fatalities.

CBD pretreatment mitigated respiratory depression from fentanyl in awake mice and significantly delayed OIPA onset in anesthetized mice, effective as the opioid antagonist naloxone.

The powerful effect of CBD pretreatment on OIPA suggests a novel therapeutic strategy to reduce fatal opioid overdose incidence.”

https://pubmed.ncbi.nlm.nih.gov/39314412/

https://www.biorxiv.org/content/10.1101/2024.09.13.612358v1

“Naloxone is a life-saving medication that can reverse an overdose from opioids—including heroin, fentanyl, and prescription opioid medications—when given in time.”

https://www.cdc.gov/stop-overdose/caring/naloxone.html#:~:text=What%20is%20naloxone%3F,use%20and%20small%20to%20carry.

Leave a Reply

Your email address will not be published. Required fields are marked *